Healthcare Market News (News) October 1999 The National Institute for Clinical Excellence (NICE) has recommended that the flu drug Relenza, developed by Glaxo Wellcome, should…
About LaingBuisson
LaingBuisson has been serving clients for over 30 years with insights, analysis and data on market structures, policy and strategy across healthcare, social care and education.
Contact us: [email protected]
Follow LaingBuisson
©2024 All rights reserved LaingBuisson 
